WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 11, 2004, 24(6):1305-1311; doi:10.1523/JNEUROSCI.2885-03.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (42)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pernar, L.
Right arrow Articles by Valentino, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pernar, L.
Right arrow Articles by Valentino, R. J.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Selective Activation of Corticotropin-Releasing Factor-2 Receptors on Neurochemically Identified Neurons in the Rat Dorsal Raphe Nucleus Reveals Dual Actions

Luise Pernar,1 Andre L. Curtis,1 Wylie W. Vale,2 Jean E. Rivier,2 and Rita J. Valentino1

1The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, and 2The Salk Institute, La Jolla, California 92037

The dorsal raphe (DR)-serotonin (5-HT) system has been implicated in stress-related psychiatric disorders. Stress may impact on this system through corticotropin-releasing factor (CRF), which densely innervates the DR. CRF binds to CRF-R1 and CRF-R2 receptors in the DR and has complex and opposing effects depending on the dose used and the endpoint examined. To clarify the impact of CRF on the DR-5-HT system, the effects of selectively activating CRF-R2 receptors (the predominant subtype) on extracellular DR neuronal activity were examined in halothane-anesthetized rats. Because the DR is neurochemically heterogeneous, when possible, neurons were labeled with neurobiotin for subsequent neurochemical classification as 5-HT or non-5-HT. Relatively low doses of urocortin II (UII) (0.1-10 ng) injected into the DR inhibited most (79%; n = 34) neurons, whereas a higher dose (30 ng) inhibited 28% and activated 41% (n = 29). An analysis of effects on neurochemically identified neurons revealed that 5-HT neurons were inhibited by 0.1-10 ng of UII and activated by 30 ng of UII. Activation of 5-HT neurons by 30 ng of UII likely resulted from disinhibition because the majority of non-5-HT neurons were inhibited by this dose. Antisauvagine-30, but not antalarmin, antagonized UII, implicating CRF-R2 receptors in the effects. The results suggest that activation of CRF-R2 on DR-5-HT neurons inhibits neuronal activity, whereas activation of CRF-R2 receptors on non-5-HT neurons may indirectly excite DR-5-HT neurons through disinhibition. Importantly, the tone of the DR-5-HT system can be regulated in a dynamic manner through CRF-R2 activation, being either decreased or increased depending on the level of endogenous or exogenous ligand.

Key words: urocortin II; serotonin; antalarmin; antisauvagine-30; stress; juxtacellular labeling; neurobiotin


Received June 10, 2003; revised December 15, 2003; accepted December 17, 2003.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. Lukkes, S. Vuong, J. Scholl, H. Oliver, and G. Forster
Corticotropin-Releasing Factor Receptor Antagonism within the Dorsal Raphe Nucleus Reduces Social Anxiety-Like Behavior after Early-Life Social Isolation
J. Neurosci., August 12, 2009; 29(32): 9955 - 9960.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. G. Kirby, E. Freeman-Daniels, J. C. Lemos, J. D. Nunan, C. Lamy, A. Akanwa, and S. G. Beck
Corticotropin-Releasing Factor Increases GABA Synaptic Activity and Induces Inward Current in 5-Hydroxytryptamine Dorsal Raphe Neurons
J. Neurosci., November 26, 2008; 28(48): 12927 - 12937.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. A. Rissman, K.-F. Lee, W. Vale, and P. E. Sawchenko
Corticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation
J. Neurosci., June 13, 2007; 27(24): 6552 - 6562.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Henry, W. Vale, and A. Markou
The Effect of Lateral Septum Corticotropin-Releasing Factor Receptor 2 Activation on Anxiety Is Modulated by Stress
J. Neurosci., September 6, 2006; 26(36): 9142 - 9152.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. B. Risbrough, R. L. Hauger, A. L. Roberts, W. W. Vale, and M. A. Geyer
Corticotropin-Releasing Factor Receptors CRF1 and CRF2 Exert Both Additive and Opposing Influences on Defensive Startle Behavior
J. Neurosci., July 21, 2004; 24(29): 6545 - 6552.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-